CLINICAL TRIALS PROFILE FOR BRILACIDIN
✉ Email this page to a colleague
Clinical Trials for Brilacidin
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT02052388 ↗ | Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections | Completed | Cellceutix Corporation | Phase 2 | The purpose of this study is to determine the safety and efficacy of three different dosing regimens of brilacidin compared to daptomycin for the treatment of serious skin infections. This study will aid in selecting the appropriate dose of brilacidin for later stage studies. |
NCT02324335 ↗ | Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer | Completed | Cellceutix Corporation | Phase 2 | Oral Mucositis (OM) is a painful and debilitating side effect of many of the drug/radiation regimens used to treat cancer. This study examines the investigational drug brilacidin and its possible application in prevention of oral mucositis in patients undergoing chemoradiation for treatment of head and neck cancer. |
NCT02324335 ↗ | Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer | Completed | Innovation Pharmaceuticals, Inc. | Phase 2 | Oral Mucositis (OM) is a painful and debilitating side effect of many of the drug/radiation regimens used to treat cancer. This study examines the investigational drug brilacidin and its possible application in prevention of oral mucositis in patients undergoing chemoradiation for treatment of head and neck cancer. |
NCT04240223 ↗ | A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers | Completed | Innovation Pharmaceuticals, Inc. | Phase 1 | This is a single-centre, blinded, randomized, placebo controlled, dose escalation study. Up to 9 healthy male volunteers will participate in the study. This study is designed to investigate the use of delayed release tablets for colonic delivery of Brilacidin. |
NCT04784897 ↗ | A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 | Completed | Innovation Pharmaceuticals, Inc. | Phase 2 | The study will assess the efficacy and safety of Brilacidin for the treatment of COVID-19 in hospitalized participants |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Brilacidin
Condition Name
Clinical Trial Locations for Brilacidin
Trials by Country
Clinical Trial Progress for Brilacidin
Clinical Trial Phase
Clinical Trial Sponsors for Brilacidin
Sponsor Name